Effects of aggressive dosing of atorvastatin on the expression of SOCS1 in CD4 + Tlymphocytes from patients with unstable angina pectoris during peri-operative period of PCI
10.3760/cma.j.issn.1671-0282.2014.03.018
- VernacularTitle:强化阿托伐他汀对不稳定型心绞痛患者PCI围术期CD4+T淋巴细胞SOCS1表达的影响
- Author:
Qiang SU
;
Lang LI
;
Jiangyou WANG
;
Weiqiang HUANG
;
You ZHOU
;
Weiming WEN
;
Yongguang LU
- Publication Type:Journal Article
- Keywords:
Unstable angina;
Atorvastatin;
CD4+T lymphocytes;
SOCS1;
IFN-γ
- From:
Chinese Journal of Emergency Medicine
2014;23(3):320-324
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of aggressive dosing of atorvastatin on the expression of SOCS1 in CD4 + Tlymphocytes from patients with unstable angina pectoris during peri-operative period of PCI.Methods A cohort of 50 patients with unstable angina pectoris were randomized (random number) to give pretreatment with either an aggressive dose (80 mg/d,n =25) or a routine dose (20 mg/d,n =25)of atorvastatin.Circulating CD4 +T cells were subsequently obtained prior to PCI,and also 18 h to 24 hours after PCI,using a magnetic cell sorting system (MACS).Fluorescence-based quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure expressions of SOCSI mRNA in the isolated CD4 + Tlymphocytes,and western blot analysis was used to detect levels of SOCS1 protein.Serum levels of IFN-γwere quantified using enzyme-linked immunosorbent assays (ELISAs).Results Compared with routine dose group,the expressions of SOCS1 mRNA and protein levels were dramatically increased and those were higher in aggressive dose group following PCI (P ＜ 0.05).In contrast,serum levels of IFN-γsignificantly increased following PCI in both groups,but it was higher in routine dose group than in aggressive dose group (P ＜ 0.05).Conclusions Treatment with aggressive dosing of atorvastatin reduced the post-PCI myocardial inflammatory response in patients with unstable angina pectoris,possibly modulating by up-regulating SOCS1 expression in CD4 + Tlymphocytes.
